Navigation Links
Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control
Date:3/2/2012

SAN DIEGO, March 2, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the filing of a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition. Arena expects the EMA will accept the filing later this month and confirm the filing is sufficiently complete to permit a substantive review.

(Photo:  http://photos.prnewswire.com/prnh/20120302/LA63311)

"With rates of obesity tripling in many European countries over the last thirty years, there is a substantial unmet need for new treatments to manage weight," said Jack Lief, Arena's President and Chief Executive Officer. "We look forward to working with the EMA and our Rapporteur and Co-rapporteur during this centralized review process and to the potential approval of lorcaserin in E.U. member countries."

About Lorcaserin
Lorcaserin is a new chemical entity that is believed to act as a selective serotonin 2C receptor agonist. The serotonin 2C receptor is expressed in the brain, including the hypothalamus, an area believed to be involved in the control of appetite and metabolism. Arena has patents that cover lorcaserin in the United States, major European countries and other jurisdictions that in most cases are capable of continuing into 2023 without taking into account any patent term extensions or other exclusivity Arena might obtain.

Arena resubmitted to the U.S. Food and Drug Administration (FDA) the lorcaserin New Drug Application (NDA) in December 2011, and the agency assigned a new Prescription
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has ... increase market share and grab a foothold in the hydroponic, ... production capabilities and a presence in the sector, and recently ... the growth of hemp and medical marijuana, iMD is committing ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... prGCD treatment of Gaucher Disease, CARMIEL, Israel, Aug. ... announced that it has treated the,first patient in its ... prGCD, a proprietary plant cell expressed recombinant form of,human ... storage disorder in humans. The phase III clinical ...
... Acute, Radiation Syndrome or Radiotherapy Adjuvant Likely Targeting Adult ... ... SCOTTSDALE, Ariz., Aug. 27 ImmuneRegen,BioSciences, Inc., a wholly ... today announced that initial studies at,TD2 (TGen Drug Development Services), ...
Cached Medicine Technology:Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD 3ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 2ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 3ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 4
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... 2015 Carinsurancesavings.biz has released a new blog ... dismemberment insurance . , Purchasing an accidental death and ... advantageous. This type of rider provides benefits if the insured ... considered a lesser form of life insurance. , AD&D ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... 2015 Recently, Weddingshe.com has added many trendy ... announced its highest annual revenues in the past three years. ... glamorous wedding dresses. , According to the sales manager of ... promotions for them in 2015. This point can be reflected ...
(Date:1/22/2015)... January 22, 2015 Four years since the release ... which coincided with the marriage of Avasa & Matthew Love – ... which is scheduled for release through White Swan Records on February ... there is a sacred path available to all of us to ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... a leading healthcare provider of interim and executive placement and consulting ... of board and CEO services. Formerly vice president, senior executive search, ... roles for hospitals, home care companies, health systems and national healthcare ... ...
... MINNEAPOLIS, Dec. 12 Crossing the finish line ... is a dream that almost didn,t come true for 34 year-old ... the triathlon, which involved a 2.4-mile swim in the Pacific Ocean, ... using a handcycle and a 26.2 mile run that Jason completed ...
... seen, study says , , FRIDAY, Dec. 12 (HealthDay News) -- ... prove to be a valuable new weapon in the crusade ... drug, known as lorcaserin, resulted in substantial weight loss in ... novel mechanism and we think it can bring very robust ...
... idea written on the back of an envelope have the ... Health (SOPH) Dean Max Michael, M.D., talking about the origins ... money grant project for health research. The awards are funded ... an interesting way to allow people to be creative, identify ...
... This morning the Department of Health was notified ... the decision to close the hospital effective today. ... of Health has revoked the hospital,s license. The ... seek emergency treatment since Commonwealth Medical Center is unable ...
... study says , , FRIDAY, Dec. 12 (HealthDay News) -- ... recurrence risk and response to cancer treatment by looking ... a panel of experts report. , The scientists presented ... San Antonio Breast Cancer Symposium in Texas. , Patients ...
Cached Medicine News:Health News:Noland Named Vice President, Board & CEO Services for B. E. Smith 2Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 2Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 3Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 4Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 5Health News:Experimental Weight-Loss Pill Passes Early Test 2Health News:Experimental Weight-Loss Pill Passes Early Test 3Health News:Inaugural Back of the Envelope Awards fund creative health research 2Health News:Progress Made in Predicting Breast Cancer Risk 2Health News:Progress Made in Predicting Breast Cancer Risk 3
Adsons bayonet forceps....
... Medpor Channel Implants, designed to ... the surgeon with an excellent ... wall and floor blowout defects. ... for placement of one or ...
... Rim is designed to augment ... the midface, including the inferior ... positioned in the hollow under ... Rim implant aids in restoring ...
Flattened points in vertical plane, straight shafts, cross action, round handle....
Medicine Products: